Piramal Pharma Limited annonce ses résultats consolidés pour le 1er trimestre 2025

Posted on by

BOMBAY, Inde, 26 juillet 2024 /PRNewswire/ — Piramal Pharma Limited (NSE : PPLPHARMA) (BSE : 543635), l’un des principaux laboratoires pharmaceutiques mondiaux, annonce ce jour ses résultats autonomes et consolidés pour le premier trimestre clos le 30 juin 2024. Faits saillants…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.